Pharmaceutical Care intervention on blood pressure control in Chronic Kidney Disease
- Conditions
- Kidney Disease
- Registration Number
- PACTR202303569804588
- Lead Sponsor
- Akinola Alexander A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 108
•Patients =18 years diagnosed with CKD stages 3 and 4
•CKD related to hypertension and diabetes.
•Outpatients who have been attending the renal clinic > 6 months
•CKD patients with uncontrolled BP =140/90mmHg
•Patients willing and able to give informed consent to participate in the study
•Inpatients, dialysis, ESRD (Stage 5), Post renal transplant patients
•unable or unwilling to provide consent
•institutionalized (e.g. prisoner, nursing home resident or skilled nursing facility resident)
•Pregnant or breast-feeding women
•Currently participating in an interventional clinical trial or in a research study that adds significantly to the participant’s burden
•Currently diagnosed with Acute kidney Injury, Nephrotic disease, Impaired mental status, Lupus, Sickle Cell Disease, Polycystic Kidney Disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method